|
| Status |
Public on Nov 10, 2023 |
| Title |
Cancer immunotherapy via synergistic co-activation of myeloid cells |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
37976347 |
| |
| Submission date |
May 22, 2023 |
| Last update date |
Nov 18, 2023 |
| Contact name |
Max M Wattenberg |
| E-mail(s) |
max.wattenberg@pennmedicine.upenn.edu
|
| Organization name |
University of Pennsylvania
|
| Lab |
Beatty
|
| Street address |
3400 Civic Center Blvd
|
| City |
Philadelphia |
| State/province |
PENNSYLVANIA |
| ZIP/Postal code |
19104 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (30)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE232860 |
Cancer immunotherapy via synergistic co-activation of myeloid cells [RNA-seq] |
| GSE233171 |
Cancer immunotherapy via synergistic co-activation of myeloid cells [scRNA-seq] |
|
| Relations |
| BioProject |
PRJNA975167 |
Less...
More...